Publications by authors named "Srushti Vaibhav Kesarkar"
J Clin Pharm Ther
August 2022
Article Synopsis
- The study investigates the risk of inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis in users of histamine-2 receptor antagonists (H2RAs).
- Four observational studies were included in a meta-analysis, analyzing data from nearly 9,000 participants, revealing a significantly increased risk of IBD in H2RA users compared to non-users.
- The findings suggest that both adults and children using H2RAs have a higher risk of developing IBD, highlighting the need for further large-scale observational studies to confirm these results.
